1
, Leandro Tavares Lucato 2 , Egberto Reis Barbosa 1 We have previously described the case of a patient with Wilson's disease who developed copper deficiency myeloneuropathy (CDM) 1, 2 . One year after zinc withdrawal, mild improvement of sensory symptoms was reported, with unchanged neurologic examination. Urinary copper excretion has increased from 7.4 to 80mg/24 hours and serum zinc level has decreased from 311 to 106mg/dL. Resolution of MRI findings was observed (Figure) . She remains on regular clinical monitoring. These results indicate that zinc withdrawal, without copper supplementation, was enough to prevent CDM progression in our patient. Early diagnosis and management of CDM probably have accounted for this satisfactory outcome.
